81 FR 22634 - Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 74 (April 18, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 74 (April 18, 2016)
| Page Range | 22634-22634 | |
| FR Document | 2016-08843 |
[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)] [Notices] [Page 22634] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-08843] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc. ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated December 4, 2015, and published in the Federal Register on December 10, 2015, 80 FR 76709, Cody Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Dihydromorphine (9145)..................... I Amphetamine (1100)......................... II Methamphetamine (1105)..................... II Methylphenidate (1724)..................... II Amobarbital (2125)......................... II Pentobarbital (2270)....................... II Secobarbital (2315)........................ II 4-Anilino-N-phenethyl-4-piperidine (ANPP) II (8333). Phenylacetone (8501)....................... II Cocaine (9041)............................. II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Diphenoxylate (9170)....................... II Ecgonine (9180)............................ II Hydrocodone (9193)......................... II Meperidine (9230).......................... II Methadone (9250)........................... II Methadone intermediate (9254).............. II Morphine (9300)............................ II Thebaine (9333)............................ II Oxymorphone (9652)......................... II Alfentanil (9737).......................... II Remifentanil (9739)........................ II Sufentanil (9740).......................... II Tapentadol (9780).......................... II Fentanyl (9801)............................ II ------------------------------------------------------------------------ The company plans to manufacture the listed controlled substances in bulk for sale to its customers. Dated: April 11, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-08843 Filed 4-15-16; 8:45 am] BILLING CODE 4410-09-P
![22634 Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices
(individual member), Sydney, in the Federal Register on December 10, Dated: April 11, 2016.
AUSTRALIA; Douglas McGee 2015, 80 FR 76709, Cody Laboratories, Louis J. Milione,
(individual member), Columbus, OH; Inc., 601 Yellowstone Avenue, Cody, Deputy Assistant Administrator.
and Nick Ryan (individual member), Wyoming 82414 applied to be registered [FR Doc. 2016–08843 Filed 4–15–16; 8:45 am]
London, UNITED KINGDOM, have been as a manufacturer of certain basic BILLING CODE 4410–09–P
added as parties to this venture. classes of controlled substances. No
Also, Ad-ID, New York, NY; CNN/ comments or objections were submitted
Turner Broadcasting System, Atlanta, for this notice. DEPARTMENT OF JUSTICE
GA; Masstech Group, Inc., Markham, The DEA has considered the factors in
Ontario, CANADA; Video Stream 21 U.S.C. 823(a) and determined that Drug Enforcement Administration
Networks (VSN), Barcelona, SPAIN; and the registration of Cody Laboratories,
SDVI Corporation, Menlo Park, CA, Inc. to manufacture the basic classes of [Docket No. DEA–392]
have withdrawn as parties to this controlled substances is consistent with
venture. the public interest and with United Importer of Controlled Substances
No other changes have been made in States obligations under international Registration: Research Triangle
either the membership or planned treaties, conventions, or protocols in Institute
activity of the group research project. effect on May 1, 1971. The DEA
Membership in this group research investigated the company’s maintenance ACTION: Notice of registration.
project remains open, and Advanced of effective controls against diversion by
Media Workflow Association, Inc. inspecting and testing the company’s SUMMARY: Research Triangle Institute
intends to file additional written physical security systems, verifying the applied to be registered as an importer
notifications disclosing all changes in company’s compliance with state and of certain basic classes of controlled
membership. local laws, and reviewing the company’s
On March 28, 2000, Advanced Media substances. The Drug Enforcement
background and history. Administration (DEA) grants Research
Workflow Association, Inc. filed its Therefore, pursuant to 21 U.S.C.
original notification pursuant to section Triangle Institute registration as an
823(a), and in accordance with 21 CFR importer of those controlled substances.
6(a) of the Act. The Department of 1301.33, the above-named company is
Justice published a notice in the Federal granted registration as a bulk SUPPLEMENTARY INFORMATION: By notice
Register pursuant to section 6(b) of the manufacturer of the following basic dated July 29, 2015, and published in
Act on June 29, 2000 (65 FR 40127). classes of controlled substances: the Federal Register on August 4, 2015,
The last notification was filed with 80 FR 46330, Research Triangle
the Department on December 23, 2015. Controlled substance Schedule Institute, Kenneth S. Rehder, Hermann
A notice was published in the Federal Building East Institute Drive, Room 106,
Register pursuant to section 6(b) of the Dihydromorphine (9145) ............... I Research Triangle Park, North Carolina
Act on January 22, 2016 (81 FR 3823). Amphetamine (1100) .................... II 27709–2194 applied to be registered as
Methamphetamine (1105) ............ II
Patricia A. Brink, Methylphenidate (1724) ................ II
an importer of certain basic classes of
Director of Civil Enforcement, Antitrust Amobarbital (2125) ....................... II controlled substances. No comments or
Division. Pentobarbital (2270) ..................... II objections were submitted for this
[FR Doc. 2016–08804 Filed 4–15–16; 8:45 am] Secobarbital (2315) ...................... II notice.
BILLING CODE P
4-Anilino-N-phenethyl-4-piperidine II The DEA has considered the factors in
(ANPP) (8333).
21 U.S.C. 823, 952(a) and 958(a) and
Phenylacetone (8501) .................. II
Cocaine (9041) ............................. II determined that the registration of
DEPARTMENT OF JUSTICE Codeine (9050) ............................. II Research Triangle Institute to import the
Dihydrocodeine (9120) ................. II basic classes of controlled substances is
Drug Enforcement Administration Oxycodone (9143) ........................ II consistent with the public interest and
[Docket No. DEA–392] Hydromorphone (9150) ................ II with United States obligations under
Diphenoxylate (9170) ................... II international treaties, conventions, or
Manufacturer of Controlled Ecgonine (9180) ........................... II protocols in effect on May 1, 1971. The
Substances Registration: Cody Hydrocodone (9193) ..................... II DEA investigated the company’s
Laboratories, Inc. Meperidine (9230) ........................ II
Methadone (9250) ........................ II maintenance of effective controls
Methadone intermediate (9254) ... II against diversion by inspecting and
ACTION: Notice of registration. testing the company’s physical security
Morphine (9300) ........................... II
SUMMARY: Cody Laboratories, Inc. Thebaine (9333) ........................... II systems, verifying the company’s
applied to be registered as a Oxymorphone (9652) ................... II compliance with state and local laws,
manufacturer of certain basic classes of Alfentanil (9737) ........................... II and reviewing the company’s
Remifentanil (9739) ...................... II background and history.
controlled substances. The Drug Sufentanil (9740) .......................... II
Enforcement Administration (DEA) Tapentadol (9780) ........................ II Therefore, pursuant to 21 U.S.C.
grants Cody Laboratories, Inc. Fentanyl (9801) ............................ II 952(a) and 958(a), and in accordance
registration as a manufacturer of those with 21 CFR 1301.34, the above-named
controlled substances. The company plans to manufacture company is granted registration as an
mstockstill on DSK4VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION: By notice the listed controlled substances in bulk importer of the following basic classes
dated December 4, 2015, and published for sale to its customers. of controlled substances:
Controlled substance Schedule
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)1-pentyl-1H-indazole-3-carboxamide) (7023) ................................................... I
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (7031) ......................... I
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) ............................................................................................................. I
VerDate Sep<11>2014 17:54 Apr 15, 2016 Jkt 238001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\18APN1.SGM 18APN1](https://thefederalregister.org/doc/81_FR_22708/page/1.svg)
Document Created: 2016-04-16 01:46:14
Document Modified: 2016-04-16 01:46:14
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 81 FR 22634 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR